Company Overview and News

 
Pune airport seeks international status

2018-10-16 financialexpress
The Pune Airport at Lohegaon air base is seeking an international airport status from the civil aviation ministry. This will enable more international flights to operate out of Pune. The airport is set to fly 12 million passengers next year with the number of flights increasing to 57,000 per year from 30,543 currently while cargo movement was growing at 54% y-o-y for the year till date.
509496 ITDCEM

 
An evening walk down Dalal Street | Investors lose nearly Rs 3L crore on manic Monday; Nifty gives up 11,000, Sensex down 530 pts

2018-09-24 moneycontrol
It’s a day that completely belonged to the bears, with the Sensex ending over 500 points lower. More importantly, the Nifty gave up 11,000-mark and closed below this key psychological level.
ECQRY 534690 IDKQY 532617 JETAIRWAYS 533278 535789 IBULHSGFIN 505200 RAMCOSYS LAKSHVILAS 532370 534809 509496 PCJEWELLER EICHERMOT CLNDY COALINDIA ITDCEM

 
ITD Cementation shares jump 10% on bagging orders valued at Rs 845 crore

2018-09-24 moneycontrol
ITD Cementation India share price rallied 10.34 percent intraday Monday on bagging two orders which are valued at Rs 845 crore.
509496 ITDCEM

 
Orders bode well for ITD Cementation

2018-09-21 thehindubusinessline
ITD Cementation India has received letters of acceptance/intent aggregating ₹845 crore for upgrading of passenger terminal building and airside facilities at Tiruchirapalli International Airport by the Airports Authority of India; and development of refit jetty and allied facilities at Port Blair by the Ministry of Shipping, Government of India for Andaman Lakshadweep Harbour Works. Shareholders of the company will closely monitor execution of the orders.
509496 ITDCEM

 
ITD Cementation India Limited - Press Release

2018-09-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
Broker's call: ITD Cementation (Buy)

2018-08-21 thehindubusinessline
ITD Cementation India is involved in construction and civil engineering. The company is engaged in construction of a range of structures, which include maritime structures, mass rapid transport systems (MRTS), airports and other foundations.
509496 ITDCEM

 
ITD Cementation India Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-08-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Outcome of Board Meeting

2018-08-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Updates

2018-07-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Trading Window

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Credit Rating

2018-06-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Shareholders meeting

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Shareholders meeting

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

 
ITD Cementation India Limited - Investor Presentation

2018-05-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509496 ITDCEM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...